Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer.
Tomko A, O'Leary L, Trask H, Achenbach JC, Hall SR, Goralski KB, Ellis LD, Dupré DJ.
Tomko A, et al. Among authors: o leary l.
Front Pharmacol. 2019 Sep 27;10:1124. doi: 10.3389/fphar.2019.01124. eCollection 2019.
Front Pharmacol. 2019.
PMID: 31611800
Free PMC article.
Contrary to most cannabinoids present in the Cannabis plant, some, such as O-1602 and abnormal cannabidiol, have no or only little affinity to the CB(1) or CB(2) cannabinoid receptors and instead exert their effects through other receptors. ...
Contrary to most cannabinoids present in the Cannabis plant, some, such as O-1602 and abnormal cannabidiol, have no or only little affinity …